skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 6,183  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Show only
Refined by: subject: Life Sciences & Biomedicine remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Gout
Gout
Material Type:
Article 		Add to My Research

Gout

The Lancet (British edition), 2016-10, Vol.388 (10055), p.2039-2052 [Peer Reviewed Journal]

Elsevier Ltd ;2016 Elsevier Ltd ;Copyright © 2016 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Oct 22, 2016 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(16)00346-9 ;PMID: 27112094 ;CODEN: LANCAO

Full text available

Citations Cited by
2
2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout
2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout
Material Type:
Article 		Add to My Research

2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout

Annals of the rheumatic diseases, 2020-01, Vol.79 (1), p.31-38 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;2020 Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2019-215315 ;PMID: 31167758

Full text available

Citations Cited by
3
Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout
Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout
Material Type:
Article 		Add to My Research

Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout

The New England journal of medicine, 2018-03, Vol.378 (13), p.1200-1210 [Peer Reviewed Journal]

Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1710895 ;PMID: 29527974

Full text available

Citations Cited by
4
Mechanism of Action of Colchicine in the Treatment of Gout
Mechanism of Action of Colchicine in the Treatment of Gout
Material Type:
Article 		Add to My Research

Mechanism of Action of Colchicine in the Treatment of Gout

Clinical therapeutics, 2014-10, Vol.36 (10), p.1465-1479 [Peer Reviewed Journal]

The Authors ;2014 The Authors ;2015 INIST-CNRS ;Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Oct 2014 ;ISSN: 0149-2918 ;EISSN: 1879-114X ;DOI: 10.1016/j.clinthera.2014.07.017 ;PMID: 25151572

Full text available

Citations Cited by
5
Management of gout in chronic kidney disease: a G-CAN Consensus Statement on the research priorities
Management of gout in chronic kidney disease: a G-CAN Consensus Statement on the research priorities
Material Type:
Article 		Add to My Research

Management of gout in chronic kidney disease: a G-CAN Consensus Statement on the research priorities

Nature reviews. Rheumatology, 2021-10, Vol.17 (10), p.633-641 [Peer Reviewed Journal]

2021. The Author(s). ;COPYRIGHT 2021 Nature Publishing Group ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1759-4790 ;EISSN: 1759-4804 ;DOI: 10.1038/s41584-021-00657-4 ;PMID: 34331037

Full text available

Citations Cited by
6
Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors
Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors
Material Type:
Article 		Add to My Research

Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors

Nature reviews. Rheumatology, 2020-07, Vol.16 (7), p.380-390 [Peer Reviewed Journal]

COPYRIGHT 2020 Nature Publishing Group ;Springer Nature Limited 2020. ;ISSN: 1759-4790 ;EISSN: 1759-4804 ;DOI: 10.1038/s41584-020-0441-1 ;PMID: 32541923

Full text available

Citations Cited by
7
Inflammation in gout: mechanisms and therapeutic targets
Inflammation in gout: mechanisms and therapeutic targets
Material Type:
Article 		Add to My Research

Inflammation in gout: mechanisms and therapeutic targets

Nature reviews. Rheumatology, 2017-11, Vol.13 (11), p.639-647 [Peer Reviewed Journal]

COPYRIGHT 2017 Nature Publishing Group ;COPYRIGHT 2017 Nature Publishing Group ;Copyright Nature Publishing Group Nov 2017 ;ISSN: 1759-4790 ;EISSN: 1759-4804 ;DOI: 10.1038/nrrheum.2017.155 ;PMID: 28959043

Full text available

Citations Cited by
8
British Society for Rheumatology and British Health Professionals in Rheumatology Guideline for the Management of Gout
British Society for Rheumatology and British Health Professionals in Rheumatology Guideline for the Management of Gout
Material Type:
Article 		Add to My Research

British Society for Rheumatology and British Health Professionals in Rheumatology Guideline for the Management of Gout

Rheumatology (Oxford, England), 2007-08, Vol.46 (8), p.1372-1374 [Peer Reviewed Journal]

The Author 2007. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org 2007 ;2007 INIST-CNRS ;The Author 2007. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org ;ISSN: 1462-0324 ;EISSN: 1462-0332 ;DOI: 10.1093/rheumatology/kem056a ;PMID: 17522099 ;CODEN: BJRHDF

Full text available

Citations Cited by
9
Predictors of disease activity in gout: a 12-month analysis of the ATTACk (Achieving improvement in the management of crystal-induced arthritis) multicentre cohort study
Predictors of disease activity in gout: a 12-month analysis of the ATTACk (Achieving improvement in the management of crystal-induced arthritis) multicentre cohort study
Material Type:
Article 		Add to My Research

Predictors of disease activity in gout: a 12-month analysis of the ATTACk (Achieving improvement in the management of crystal-induced arthritis) multicentre cohort study

Clinical and experimental rheumatology, 2023-03, Vol.41 (3), p.628-633 [Peer Reviewed Journal]

ISSN: 0392-856X ;ISSN: 1593-098X ;EISSN: 1593-098X ;DOI: 10.55563/clinexprheumatol/eh0jcp ;PMID: 35930471

Full text available

Citations Cited by
10
Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study)
Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study)
Material Type:
Article 		Add to My Research

Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study)

Annals of the rheumatic diseases, 2017-05, Vol.76 (5), p.811-820 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/. ;Copyright: 2016 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ 2016 ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2016-209213 ;PMID: 27821644 ;CODEN: ARDIAO

Full text available

Citations Cited by
11
Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial
Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial
Material Type:
Article 		Add to My Research

Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial

The Lancet (British edition), 2020-11, Vol.396 (10264), p.1745-1757 [Peer Reviewed Journal]

2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)32234-0 ;PMID: 33181081

Full text available

Citations Cited by
12
Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000–2005
Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000–2005
Material Type:
Article 		Add to My Research

Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000–2005

Annals of the rheumatic diseases, 2008-07, Vol.67 (7), p.960-966 [Peer Reviewed Journal]

2008 BMJ Publishing Group and European League Against Rheumatism ;2008 INIST-CNRS ;Copyright: 2008 2008 BMJ Publishing Group and European League Against Rheumatism ;Annemans et al 2008 2008 ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/ard.2007.076232 ;PMID: 17981913 ;CODEN: ARDIAO

Full text available

Citations Cited by
13
Stepwise dose increase of febuxostat is comparable with colchicine prophylaxis for the prevention of gout flares during the initial phase of urate-lowering therapy: results from FORTUNE-1, a prospective, multicentre randomised study
Stepwise dose increase of febuxostat is comparable with colchicine prophylaxis for the prevention of gout flares during the initial phase of urate-lowering therapy: results from FORTUNE-1, a prospective, multicentre randomised study
Material Type:
Article 		Add to My Research

Stepwise dose increase of febuxostat is comparable with colchicine prophylaxis for the prevention of gout flares during the initial phase of urate-lowering therapy: results from FORTUNE-1, a prospective, multicentre randomised study

Annals of the rheumatic diseases, 2018-02, Vol.77 (2), p.270-276 [Peer Reviewed Journal]

Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. ;2018 Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See:http://creativecommons.org/licenses/by-nc/4.0 ;Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. 2018 ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2017-211574 ;PMID: 29102957

Full text available

Citations Cited by
14
National prevalence of gout derived from administrative health data in Aotearoa New Zealand
National prevalence of gout derived from administrative health data in Aotearoa New Zealand
Material Type:
Article 		Add to My Research

National prevalence of gout derived from administrative health data in Aotearoa New Zealand

Rheumatology (Oxford, England), 2012-05, Vol.51 (5), p.901-909 [Peer Reviewed Journal]

2015 INIST-CNRS ;ISSN: 1462-0324 ;EISSN: 1462-0332 ;DOI: 10.1093/rheumatology/ker361 ;PMID: 22253023

Full text available

Citations Cited by
15
Ultrasound shows rapid reduction of crystal depositions during a treat-to-target approach in gout patients: 12-month results from the NOR-Gout study
Ultrasound shows rapid reduction of crystal depositions during a treat-to-target approach in gout patients: 12-month results from the NOR-Gout study
Material Type:
Article 		Add to My Research

Ultrasound shows rapid reduction of crystal depositions during a treat-to-target approach in gout patients: 12-month results from the NOR-Gout study

Annals of the rheumatic diseases, 2020-11, Vol.79 (11), p.1500-1505 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;2020 Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2020-217392 ;PMID: 32669301

Full text available

Citations Cited by
16
Pharmacodynamic, pharmacokinetic and tolerability evaluation of concomitant administration of lesinurad and febuxostat in gout patients with hyperuricaemia
Pharmacodynamic, pharmacokinetic and tolerability evaluation of concomitant administration of lesinurad and febuxostat in gout patients with hyperuricaemia
Material Type:
Article 		Add to My Research

Pharmacodynamic, pharmacokinetic and tolerability evaluation of concomitant administration of lesinurad and febuxostat in gout patients with hyperuricaemia

Rheumatology (Oxford, England), 2014-12, Vol.53 (12), p.2167-2174 [Peer Reviewed Journal]

The Author 2014. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com. ;ISSN: 1462-0324 ;EISSN: 1462-0332 ;DOI: 10.1093/rheumatology/ket487 ;PMID: 24509406

Full text available

Citations Cited by
17
EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics (ESCISIT)
EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics (ESCISIT)
Material Type:
Article 		Add to My Research

EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics (ESCISIT)

Annals of the rheumatic diseases, 2006-10, Vol.65 (10), p.1312-1324 [Peer Reviewed Journal]

Copyright 2006 by Annals of the Rheumatic Diseases ;Copyright: 2006 Copyright 2006 by Annals of the Rheumatic Diseases ;Copyright © 2006 BMJ Publishing Group Ltd & European League Against Rheumatism ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/ard.2006.055269 ;PMID: 16707532 ;CODEN: ARDIAO

Full text available

Citations Cited by
18
ABCG2 loss-of-function polymorphism predicts poor response to allopurinol in patients with gout
ABCG2 loss-of-function polymorphism predicts poor response to allopurinol in patients with gout
Material Type:
Article 		Add to My Research

ABCG2 loss-of-function polymorphism predicts poor response to allopurinol in patients with gout

The pharmacogenomics journal, 2017-03, Vol.17 (2), p.201-203 [Peer Reviewed Journal]

Copyright Nature Publishing Group Mar 2017 ;Macmillan Publishers Limited, part of Springer Nature. 2017. ;ISSN: 1470-269X ;EISSN: 1473-1150 ;DOI: 10.1038/tpj.2015.101 ;PMID: 26810134

Full text available

Citations Cited by
19
Interventions for tophi in gout
Interventions for tophi in gout
Material Type:
Article 		Add to My Research

Interventions for tophi in gout

Cochrane database of systematic reviews, 2021-08, Vol.2021 (11), p.CD010069 [Peer Reviewed Journal]

Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. ;EISSN: 1465-1858 ;EISSN: 1469-493X ;DOI: 10.1002/14651858.CD010069.pub3 ;PMID: 34379791

Full text available

Citations Cited by
20
Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapy
Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapy
Material Type:
Article 		Add to My Research

Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapy

Arthritis research & therapy, 2018-06, Vol.20 (1), p.108-108, Article 108 [Peer Reviewed Journal]

COPYRIGHT 2018 BioMed Central Ltd. ;Copyright © 2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2018 ;ISSN: 1478-6362 ;ISSN: 1478-6354 ;EISSN: 1478-6362 ;DOI: 10.1186/s13075-018-1596-x ;PMID: 29855389

Full text available

Citations Cited by

Results 1 - 20 of 6,183  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (5,670)

Refine My Results

Creation Date 

From To
Refine
  1. Before 1960  (137)
  2. 1960 To 1975  (449)
  3. 1976 To 1991  (452)
  4. 1992 To 2008  (1,045)
  5. After 2008  (4,115)
  6. More options open sub menu

Subject 

  1. Humans  (4,286)
  2. Gout  (3,510)
  3. Male  (2,536)
  4. Rheumatology  (2,093)
  5. Female  (1,816)
  6. Middle Aged  (1,721)
  7. Uric Acid  (1,544)
  8. Adult  (1,421)
  9. Aged  (1,283)
  10. General & Internal Medicine  (1,282)
  11. Medicine, General & Internal  (1,259)
  12. Rheumatism  (1,102)
  13. Biological And Medical Sciences  (1,004)
  14. Medical Sciences  (937)
  15. Gout - Drug Therapy  (927)
  16. Uric Acid - Blood  (898)
  17. Arthritis  (841)
  18. Risk Factors  (787)
  19. More options open sub menu

Language 

  1. English  (6,115)
  2. Japanese  (671)
  3. Russian  (37)
  4. German  (29)
  5. Portuguese  (27)
  6. Italian  (26)
  7. Spanish  (13)
  8. French  (7)
  9. Norwegian  (6)
  10. Ukrainian  (5)
  11. Serbian  (4)
  12. Korean  (4)
  13. Turkish  (3)
  14. Chinese  (3)
  15. Polish  (1)
  16. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait